• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

Microbiome search engine can increase efficiency in disease detection and diagnosis

April 7, 2020 Microbiome Times

Big data makes big promises when it comes to providing insights into human behavior and health. The problem is how to harness the information it provides in an efficient manner. An international team of researchers […]

Editor's Choice

A common gut microbe secretes a carcinogen

April 4, 2020 Microbiome Times

Cancer mutations can be caused by common gut bacteria carried by many people. This was demonstrated by researchers from the Hubrecht Institute (KNAW) and Princess Máxima Center in Utrecht, the Netherlands. By exposing cultured human […]

Pharma & Human Health

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

April 3, 2020 Microbiome Times

In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, Allergan and Bausch Health (backed by its Salix division) were ranked as the top companies best poised to deliver […]

Pharma & Human Health

Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19

April 3, 2020 Microbiome Times

Persephone Biosciences Inc., a biotechnology company that designs microbiome therapeutics and diagnostics to promote normal immune function in order to prevent and fight disease, today announced that it is developing an immune-boosting microbiome therapeutic to […]

Pharma & Human Health

The Promise of probiotics for male sexual health

April 1, 2020 Mohd Akram, ICAR-NDRI, Syed Azmal Ali, ICAR-NDRI and Gautam Kau, ICAR-NDRI

Overview: In recent studies, 48.5 million couples worldwide were identified as being infertile, and 50% of these were found to be due to a male infertility problem (Agarwal et al., 2015). Multiplefactors may be contributing […]

Finance

Ilya Pharma receives BIO-X® grant to complete preclinical work for novel IBD chemokine-based gene therapy candidates

March 30, 2020 Microbiome Times

Ilya Pharma a clinical stage biopharma company today announced that it has received a BIO-X® grant that will be matched with company funding to complete preclinical studies for two novel chemokine-based gene therapy candidates, ILP100 […]

Finance

Evolve BioSystems, Inc. Announces Collaboration with Janssen to Study the Impact of B. infantis EVC001 in the Reduction of Atopic Dermatitis

March 27, 2020 Microbiome Times

Evolve BioSystems, Inc., a global leader dedicated to improving human health through the gut microbiome, today announced a collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, […]

Editor's Choice

The Microbiome Biotech Landscape: An Analysis of the Pharmaceutical Pipeline

March 26, 2020 Luis Gosálbez

Introduction The microbiome is one of the hottest areas in biotechnology, as countless studies have linked its composition and activity with human disease1,2, especially in illnesses of poorly understood mechanisms, with high medical unmet needs. […]

Finance

Safety Alert Regarding Use of FMT and Additional Safety Protections Pertaining to SARS-CoV-2 and COVID-19

March 24, 2020 Microbiome Times

The global public health community is responding to a rapidly evolving pandemic of respiratory disease caused by a novel coronavirus that was first detected in China. The virus has been named “SARS-CoV-2” and the disease […]

Finance

Major Infant Health Collaboration Announced by APC Microbiome Ireland with DuPont Nutrition & Biosciences

March 15, 2020 Microbiome Times

Today, DuPont Nutrition & Biosciences (DuPont) announced a second collaboration with the APC Microbiome Ireland SFI Research Center (APC), a pioneer in the field of microbiome science, which focuses on microbes that live in and […]

Editor's Choice

FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Events Likely Due to Transmission of Pathogenic Organisms

March 13, 2020 Microbiome Times

The Food and Drug Administration (FDA) is informing health care providers and patients of the potential risk of serious or life-threatening infections with the use of fecal microbiota for transplantation (FMT). The agency is now aware […]

Posts navigation

« 1 … 48 49 50 … 85 »

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter